IFNL1 and non-small cell lung carcinoma: Sera and bronchoalveolar lavage fluid (BALF) taken prior to chemotherapy from patients diagnosed with non-small cell lung cancer (NSCLC) were analyzed by enzyme linked immunosorbent assay (ELISA) to assess circulating levels of IL-27, IL-29, IL-31, and IL-33.